# Fluence Therapeutics Inc. — Form D

Fluence Therapeutics Inc. of AKRON, OH, a company, filed a Form D exempt-offering notice with the SEC on 2013-05-03. The offering totals $200K, of which $150K was reported sold. Industry: Other.

## Offering

- Filed: 2013-05-03
- Form: D
- Accession: 0001575946-13-000001
- Industry: Other
- Exemptions: 05, 06, 04.3
- Total offering: $200K
- Amount sold: $150K
- Remaining: $50K
- Minimum investment: $10K
- Investors: 8
- Date of first sale: 2013-04-19
- Security types: debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-195946

## Issuer

- Name: Fluence Therapeutics Inc.
- CIK: 0001575946
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 526 SOUTH MAIN STREET, AKRON, OH, 44311
- Phone: 330 294 0105

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Stephen Behm | Director | Cleveland, OH |
| Warren Goldenberg | Director | Shaker Heights, OH |
| Warren Goldenberg | Executive Officer | Shaker Heights, OH |
| Nancy Oleinick | Executive Officer | University Heights, OH |
| Warren Goldenberg | Promoter | Shaker Heights, OH |

## More

- [CIK 1575946 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1575946&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001575946-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.